CooperVision Launches MyDay® MiSight® 1 Day Contact Lenses for Myopia Control

Introduction to MyDay® MiSight® 1 Day

CooperVision has recently announced the upcoming launch of their innovative MyDay® MiSight® 1 day contact lenses, aimed specifically at managing myopia in children. This initiative expands their existing portfolio of evidence-based solutions for myopia control, addressing a growing concern among eye care professionals and parents alike.

The Importance of Addressing Myopia

According to recent studies, it is estimated that one in two children born today might develop myopia by the age of 20. Myopia can severely impact the quality of life, affecting various activities such as learning in school and sports participation. The rapid progression of myopia, especially in younger children, underscores the importance of early intervention.

Establishing effective myopia control solutions has become a paramount focus for companies like CooperVision, which are committed to enhancing the quality of vision for younger populations. Debbie Olive, CooperVision's Director of Sales, emphasized the company's dedication to combating myopia through scientific and commercial means, underscoring the potential life-changing benefits of their new lenses.

MyDay® MiSight® Technology

The MyDay® MiSight® 1 day lenses integrate the established MiSight® technology with advanced silicone hydrogel material. This unique combination leverages the ActivControl® technology designed to slow myopia progression by approximately 50%, as verified by extensive clinical studies focused on soft contact lenses for children. The design of these lenses features distinct vision correction zones and treatment areas that facilitate clear vision while simultaneously controlling the progression of myopia.

Jennifer Lambert, Vice President of Myopia Control and Corneal Care at CooperVision, highlighted the innovation, stating, "This solution provides continuous myopia control—children can benefit from treatment simply by wearing contact lenses throughout their day." These lenses also aim to ensure a smooth transition from myopia control lenses to adult lenses, as they are made from the same material and have the same parameters as existing MyDay® lenses.

Product Availability and Specifications

The MyDay® MiSight® 1 day lenses are set to be available in the UK and select European markets. The specifications for these lenses are as follows:

- Spherical Power Range: -0.25 to -6.00 (0.25D); -6.50 to -10.00 (0.50D)

As part of their commitment to myopia management, CooperVision emphasizes the importance of addressing these critical vision issues in early stages of childhood to mitigate future health ramifications related to poor vision.

CooperVision’s Legacy in Eye Care

For decades, CooperVision has worked tirelessly to tackle some of the most challenging vision problems, including astigmatism and presbyopia, thereby delivering a comprehensive range of spherical, toric, and multifocal products on the market. Their dedication extends beyond manufacturing innovative lenses; they also provide targeted support for eye care professionals, ultimately leading to improved visual outcomes for patients.

With over 15,000 employees globally, CooperCompanies (parent company of CooperVision) maintains a significant presence in medical device production and aims to positively affect the lives of more than 50 million people each year. Their reach spans across more than 130 countries.

For further details regarding this innovative product and their science-backed efforts in myopia management, visit https://coopervision.co.uk/.

Conclusion

The introduction of MyDay® MiSight® 1 day lenses signifies an important step forward in the realm of vision correction for children, promising not only to curb the rapid progression of myopia but also to enhance the daily lives of countless young individuals. As awareness continues to grow about the implications of myopia, CooperVision remains at the forefront of pioneering solutions that blend advanced technology with a commitment to improving vision health among younger generations.